Pioneer in Pharmaceutical Royalty
Monetization

Building a diversified portfolio of interests in medicines with a focus on those that effectively treat and address unmet medical needs.

Tailored
Offerings

A best-in-class partner for investors and innovators alike, with multiple repeat deal partners, and offering unique, creative and flexible structures to meet counterparty needs.

A Diversified Portfolio
of Interests

As a smart capital allocator, we acquire dependable, patent-protected cash flow streams derived from the sales of important drugs across multiple therapeutic areas.

0
Years
of Experience
0
Royalties
On 45+ drugs
$ 0 +
Billion
Deployed

Portfolio

Driving Value Creation

Actively sourcing royalty streams on medically necessary products with long-term patent protection and high growth potential.

Investors

We provide uniquely favourable exposure for investors through a diversified, risk-mitigated portfolio of therapeutic assets that aims to generate attractive returns and significant growth potential.

karim ghantous dxS2okXd zo unsplash